| Drug Name |
Quinapril hydrochloride |
| Drug ID |
BADD_D01891 |
| Description |
Quinapril is the ethyl ester prodrug of the non-sulfhydryl angiotensin converting enzyme inhibitor quinaprilat.[L8420,L8423] It is used to treat hypertension and heart failure.[L8420,L8423] ACE inhibitors are commonly used as a first line therapy in the treatment of hypertension, along with thiazide diuretics or beta blockers.[A184844]
Quinapril was granted FDA approval on 19 November 1991.[L8420] A combination tablet with [hydrochlorothiazide] was also approved on 28 December 1999.[L8423] |
| Indications and Usage |
Quinapril is indicated for the treatment of hypertension and as an adjunct therapy in the treatment of heart failure.[L8420] Quinapril in combination with hydrochlorothiazide is indicated for the treatment of hypertension.[L8423] |
| Marketing Status |
approved; investigational |
| ATC Code |
C09AA06 |
| DrugBank ID |
DB00881
|
| KEGG ID |
D00459
|
| MeSH ID |
D000077583
|
| PubChem ID |
54891
|
| TTD Drug ID |
D0I7SZ
|
| NDC Product Code |
65862-368; 63187-874; 65862-620; 63827-1009; 63629-7934; 65862-617; 65862-619; 17404-0015; 0071-0530; 0071-0527; 0071-0532; 65862-618; 0071-0535; 15308-0500 |
| UNII |
33067B3N2M
|
| Synonyms |
Quinapril | 2-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid | Accupril | CI 906 | CI-906 | Quinapril Hydrochloride | PD 109452-2 | PD 109452 2 | PD 1094522 | PD-109,452-2 | PD 109,452 2 |
